| Year | President | Location | Distinguished Lecturer | Linton Lecturer |
|---|---|---|---|---|
| 2024 | Robert Cambria | Portland, ME | Michael Conte, MD Vein Bypass Surgery for Limb Ischemia: Past is Prologue | Jean M. Panneton, MD, FACS, FRCSC The Changing Landscape of Aortic Surgery |
| 2023 | Sean P. Roddy | Boston, MA | Alan B. Lumsden, MD Reflections & Opportunities in Vascular Surgery | Gilbert R. Upchurch, Jr., MD Be Curious |
| 2022 | Andres Schanzer | Newport, RI | Vincent Rowe, MD Demographic and Social Determinants of Vascular Outcomes | Stéphan Haulon, MD The Evolution of Aortic Technology and What is Coming Next |
| 2021 | Alan Dardik | Cape Neddick, ME | Joseph L. Mills, MD, FACS If You Do Not Change Direction, You May End Up Where You Are Heading | April J. Boyd, MD, PhD, FRCSC New Insights into Abdominal Aortic Aneurysm Rupture |
| 2020 | Marc Schermerhorn | Virtual | ||
| 2019 | Richard. J. Powell | Providence, RI | Jack Cronenwett, MD The Vascular Quality Initiative: Innovation and Inspiration from New England | Peter A. Schneider, MD Where Do Innovations Come From? |
| 2018 | Glenn M. LaMuraglia | Cape Neddick, ME | Bruce Perler, MD An Evidence-Based Approach to Asymptomatic Carotid Artery Disease: Nihilism is Not Appropriate or Acceptable | Michael Jaff, DO The Changing Healthcare Environment: What this Means for the Vascular Specialist |
| 2017 | Michael T. Watkins | Boston, MA | Bao-Ngoc Nguyen, MD Vascular Surgeons and Wound Healing – Beyond the Successful Revascularization | Omaida C. Velazquez, MD Leap Forward Innovations in Vascular Disease: The Surgeon’s Role |
| 2016 | Robert B. Patterson | Stowe, VT | Spence M. Taylor, MD Lower Extremity Peripheral Arterial Disease: A Perspective After 25 Years | |
| 2015 | Mark F. Fillinger | Newport, RI | Tara Mastracci, MD Ensuring the Durability of Endovascular Aortic Repair | |
| 2014 | R. Clement Darling | Boston, MA | Joseph P. Vacanti, MD Regenerative Medicine Through the Eyes of a Surgeon | |
| 2013 | Michael Belkin | Stowe, VT | Paul Ridker, MD, MPH Inflammation and Atherothrombosis: Where Have We Been? Where Are We Going? | |
| 2012 | Bauer E. Sumpio | Boston, MA | Professor Christos Liapis Carotid Artery Interventions in the Post-RCTs Era | Frans Moll, MD, PhD, Professor Reflections on Predicting the Unpredictable AAA |
| 2011 | Frank B. Pomposelli | Providence, RI | Glenn D. Steele, Jr., MD, PhD Re-Engineering Systems of Care – Surgical Leadership | Frank W. LoGerfo, MD The Biology of Vascular Injury |
| 2010 | Jens Eldrup-Jorgensen | Rockport, ME | David Hanscom, MD & David Elaimy Awake at the Wound | Jack L. Cronenwett, MD The Role of Vascular Surgeons in Quality |
| 2009 | Richard P. Cambria | Boston, MA | Ronald L. Dalman, MD Modifiable Risks for Aneurysm Progression: Updates From the Stanford SCCOR in AAA Disease | Robert Rutherford, MD Changing Perspectives in the Management of Abdominal Aortic Aneurysm |
| 2008 | Daniel B. Walsh | Newport, RI | Brian H. Annex, MD Advances in Lower Extremity PAD: From Genetics to Novel Therapeutics | Peter Gloviczki, MD Open Venous Surgery in the Era of the Endovenous Revolution |
| 2007 | William C. Mackey | Ledyard, CT | Paul Friedmann, MD Surgical Competence | |
| 2006 | Magruder C. Donaldson | Boston, MA | Anthony D. Whittemore, MD, FACS Impact of Professionalism of Safe Surgical Care | Daniel Levy, MD Toward A Modern Understanding of Vascular Disease: The Journey From Futility to Promise |
| 2005 | Robert M. Zwolak | Stowe, VT | Patrick Morrisey, JD The Impact of the MMA: Healthcare From the Inside | Richard M. Green, MD Challenges for the Practicing Vascular Surgeon |
| 2004 | David B. Pilcher | Whitefield, NH | Julie Freischlag, MD Abdominal Aortic Aneurysms: How Things Have Changed Over 50 Years | Edith Tzeng, MD Molecular Therapies and the Vascular Surgeon |
| 2003 | William Abbott | Newport, RI | Wesley S. Moore, MD 50 Years of Progress in the Management and Prevention of Ischemic Stroke | Judah Folkman, MD Angiogenesis-Dependent Disease |
| 2002 | James O. Menzoian | Rockport, ME | Peter J. Deckers, MD Professionalism, Quality and an Evolving Health Care Delivery System | John A. Mannick, MD Fifty Years of Infrainguinal Reconstruction: What Have We Learned |
| 2001 | Frank W. LoGerfo | Providence, RI | Colleen M. Brophy, MD Stress of Life From Man to Molecules | Gregario A. Sicard, MD The Impact of Endovascular Surgeons in the Training of Vascular Residents |
| 2000 | David C. Brewster | Boston, MA | Thomas Fogarty, MD Vascular Surgeons in the New Millennium | William M. Abbott, MD The Science of Arterial Prosthesis: Past Frustrations and Future Promise |
| 1999 | Carl E. Bredenberg | Chatham, MA | C. Melville Williams, MD What We Know and Don’t Know About the Natural History of Dissecting Aneurysms of the Descending Thoracic Aorta: Implications for Stent Graft Therapy | Thomas Maciag, PhD Molecular Mechanisms of Angiogenesis |
| 1998 | Jack L. Cronenwett | Toronto, ON | James C. Stanley, MD Renovascular Hypertension at the Close of the Millennium: Pharmacologic, Endovascular and Conventional Surgical Therapy | Robert S. Langer, ScD Biomaterials and How They Will Change Our Lives |
| 1997 | Anthony D. Whittemore | Lake George, NY | Juan C. Parodi, MD Evolution and Current Results of Endovascular Aneurysm Repair | Victor Dzau, MD Gene Transfection Therapy for Preventing Vein Graft Stenosis in Infrainguinal Grafts |
| 1996 | John J. Skillman | Dixville Notch, NH | F. William Blaisdell, MD Heparin: Controversies and Misconceptions | Margot Kruskall, MD Creating a Universal Blood Supply: The Enzymatic Conversion to Group O of A and B Red Cells |
| 1995 | John A. Mannick | Montreal, QB | James S. T. Yao, MD Vascular Injuries in Athletes | Peter Libby, MD Regulation of the Stability of Atherosclerotic Plaques |
| 1994 | Thomas F. O’Donnell, Jr. | Newport, RI | Frank J. Veith, MD Endovascular Stented Grafts: Role and Impact on Vascular Surgeons | Jeffrey A. Gelfrand, MD A New Role for Coagulation and the Platelet in Atherogenesis: Modulation of Cytokine Synthesis |
| 1993 | Bruce S. Cutler | Cambridge, MA | Norman R. Hertzer, MD Health Care Reform in Vascular Surgery: Where We Stand and How We Got There | Valentin Fuster, MD Pathogenesis of Atherosclerosis: New Advances Based on the Understanding of Coronary Vascular Biology |
| 1992 | Paul Friedmann | Dixville Notch, NH | Robert W. Barnes, MD Vascular Surgery: The Burr Under the Saddle | Robert S. Lees, MD Arteriosclerosis: A Reversible Disease |
| 1991 | Michael Hume | Jesse E. Thompson, MD Some Observations of Vascular Surgery History | Michael A. Gimbrone, Jr., MD Vascular Endothelial Leukocyte Interactions: Molecular Mechanisms and Pathophysiological Consequences | |
| 1990 | Robert W. Hopkins | Alexander W. Clowes, MD Prevention of Stenosis After Vascular Reconstruction: Pharmacological Control of Intimal Hyperplasia | John A. Mannick, MD Reflections on Surgery for Aortic Aneurysm | |
| 1989 | H. Brownell Wheeler | D. Eugene Strandness, Jr., MD The Non-Invasive Evaluation of Renovascular and Mesenteric Artery Occlusive Disease | Allan D. Callow, MD Gene Therapy and the Vascular Surgeon | |
| 1988 | Nathan P. Couch | John J. Bergan, MD Problems in the Popliteal Fossa | ||
| 1987 | Thomas J. Donovan | Lester R. Sauvage, MD A Unified Perspective of Arterial Graft | ||
| 1986 | Donald C. Nabseth | Robert A. Leather, MD Current Status of In Situ Saphenous Vein Bypass Grafting | ||
| 1985 | Horace C. Stansel, Jr. | |||
| 1984 | Edwin W. Salzman | |||
| 1983 | Edward A. Edwards | |||
| 1982 | Rodger E. Weismann | |||
| 1981 | R. Clement Darling, Jr. | |||
| 1980 | William W.L. Glenn | |||
| 1979 | Richard Warren | |||
| 1978 | Allan D. Callow | |||
| 1977 | Fiorindo A. Simeone | |||
| 1976 | Frank C. Wheelock, Jr. | |||
| 1975 | Ralph A. Deterling, Jr. | |||
| 1974 | Robert R. Linton |
